224
Views
0
CrossRef citations to date
0
Altmetric
Review Articles

Insights into the metabolism, signaling, and physiological effects of 2’,3’-cyclic nucleotide monophosphates in bacteria

&
Pages 118-131 | Received 06 Oct 2023, Accepted 20 Nov 2023, Published online: 08 Dec 2023
 

Abstract

2’,3’-cyclic nucleotide monophosphates (2’,3’-cNMPs) have been discovered within both prokaryotes and eukaryotes in the past decade and a half, raising questions about their conserved existence in cells. In plants and mammals, wounding has been found to cause increased levels of 2’,3’-cNMPs. Roles for 2’,3’-cNMPs in plant immunity suggest that their regulation may be valuable for both plant hosts and microbial pathogens. In support of this hypothesis, a plethora of microbial enzymes have been found with activities related to these molecules. Studies in bacteria suggest that 2’,3’-cNMPs are also produced in response to cellular stress and modulate expression of numerous genes. 2’,3’-cNMP levels affect bacterial phenotypes, including biofilm formation, motility, and growth. Within E. coli and Salmonella enterica, 2’,3’-cNMPs are produced by RNA degradation by RNase I, highlighting potential roles for Type 2 RNases producing 2’,3’-cNMPs in a range of organisms. Development of cellular tools to modulate 2’,3’-cNMP levels in bacteria has allowed for interrogation of the effects of 2’,3’-cNMP concentration on bacterial transcriptomes and physiology. Pull-downs of cellular 2’,3’-cNMP binding proteins have identified the ribosome and in vitro studies demonstrated that 2’,3’-cNMPs decrease translation, suggesting a direct mechanism for 2’,3-cNMP-dependent control of bacterial phenotypes. Future studies dissecting the cellular roles of 2’,3’-cNMPs will highlight novel signaling pathways within prokaryotes and which can potentially be engineered to control bacterial physiology.

Acknowledgments

The authors are grateful for funding of this work supported by the National Institutes of Health [R01GM125842 to E.E.W.] and Penn State University.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.